Characterization of actionable genetic alterations to guide targeted therapy for metastatic urothelial carcinoma Meeting Abstract
| Authors: | Almassi, N.; Pietzak, E. J.; Funt, S. A.; Schultz, N.; Dalbagni, G.; Bochner, B. H.; Al-Ahmadie, H.; Bajorin, D. F.; Rosenberg, J. E.; Iyer, G.; Solit, D. B. |
| Abstract Title: | Characterization of actionable genetic alterations to guide targeted therapy for metastatic urothelial carcinoma |
| Meeting Title: | 2019 Genitourinary Cancers Symposium |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 37 |
| Issue: | 7 Suppl. |
| Meeting Dates: | 2019 Feb 14-16 |
| Meeting Location: | San Francisco, CA |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2019-03-01 |
| Language: | English |
| ACCESSION: | WOS:000489108800423 |
| DOI: | 10.1200/JCO.2019.37.7_suppl.407 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 407 -- Source: Wos |
Altmetric
Citation Impact
BMJ Impact Analytics
